

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 6.56590606 |
| 2 | cAMP biosynthetic process (GO:0006171) | 6.48383583 |
| 3 | positive regulation of vascular permeability (GO:0043117) | 6.04316708 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.95891193 |
| 5 | cGMP-mediated signaling (GO:0019934) | 5.81129087 |
| 6 | locomotory exploration behavior (GO:0035641) | 5.69432341 |
| 7 | hair cycle (GO:0042633) | 5.60354526 |
| 8 | molting cycle (GO:0042303) | 5.60354526 |
| 9 | citrulline biosynthetic process (GO:0019240) | 5.59826779 |
| 10 | cAMP metabolic process (GO:0046058) | 5.59314196 |
| 11 | cAMP catabolic process (GO:0006198) | 5.59051178 |
| 12 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.38806676 |
| 13 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.33361094 |
| 14 | citrulline metabolic process (GO:0000052) | 5.11111071 |
| 15 | positive regulation of prostaglandin secretion (GO:0032308) | 4.95269174 |
| 16 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.94294499 |
| 17 | glutamate secretion (GO:0014047) | 4.93377016 |
| 18 | negative regulation of vascular permeability (GO:0043116) | 4.91077434 |
| 19 | cyclic nucleotide catabolic process (GO:0009214) | 4.89549259 |
| 20 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.84757257 |
| 21 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.82920230 |
| 22 | sodium ion export (GO:0071436) | 4.79814065 |
| 23 | synaptic vesicle exocytosis (GO:0016079) | 4.79299751 |
| 24 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.72373998 |
| 25 | vocalization behavior (GO:0071625) | 4.72217195 |
| 26 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.69135296 |
| 27 | urea cycle (GO:0000050) | 4.47030306 |
| 28 | layer formation in cerebral cortex (GO:0021819) | 4.46145500 |
| 29 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.45289672 |
| 30 | cellular potassium ion homeostasis (GO:0030007) | 4.45271863 |
| 31 | glomerular visceral epithelial cell development (GO:0072015) | 4.44762423 |
| 32 | regulation of prostaglandin secretion (GO:0032306) | 4.44722076 |
| 33 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.44044869 |
| 34 | carnitine shuttle (GO:0006853) | 4.44018732 |
| 35 | nuclear pore complex assembly (GO:0051292) | 4.42441758 |
| 36 | regulation of synapse structural plasticity (GO:0051823) | 4.39524606 |
| 37 | neurotransmitter secretion (GO:0007269) | 4.33984131 |
| 38 | desmosome organization (GO:0002934) | 4.33125850 |
| 39 | negative regulation of catenin import into nucleus (GO:0035414) | 4.32621389 |
| 40 | regulation of synaptic vesicle transport (GO:1902803) | 4.31608961 |
| 41 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 4.30107456 |
| 42 | regulation of cell communication by electrical coupling (GO:0010649) | 4.28897173 |
| 43 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.28412901 |
| 44 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.25915441 |
| 45 | regulation of relaxation of muscle (GO:1901077) | 4.24676854 |
| 46 | activation of protein kinase A activity (GO:0034199) | 4.19513996 |
| 47 | glycine transport (GO:0015816) | 4.19396418 |
| 48 | exploration behavior (GO:0035640) | 4.15128339 |
| 49 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.09136867 |
| 50 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.09089092 |
| 51 | glomerular basement membrane development (GO:0032836) | 4.08576910 |
| 52 | response to inactivity (GO:0014854) | 4.05946086 |
| 53 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.05356298 |
| 54 | response to dexamethasone (GO:0071548) | 4.03715222 |
| 55 | glomerular epithelial cell development (GO:0072310) | 4.03391400 |
| 56 | gamma-aminobutyric acid transport (GO:0015812) | 4.02939262 |
| 57 | neuronal action potential propagation (GO:0019227) | 4.00135492 |
| 58 | proline transport (GO:0015824) | 3.99316796 |
| 59 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.94447847 |
| 60 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.91418525 |
| 61 | urea metabolic process (GO:0019627) | 3.90465554 |
| 62 | midgut development (GO:0007494) | 3.86137224 |
| 63 | neuromuscular process controlling balance (GO:0050885) | 3.85446578 |
| 64 | cellular response to glucagon stimulus (GO:0071377) | 3.84580949 |
| 65 | glomerular filtration (GO:0003094) | 3.83696238 |
| 66 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.83158375 |
| 67 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.82396892 |
| 68 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.81319677 |
| 69 | carnitine transmembrane transport (GO:1902603) | 3.80054857 |
| 70 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.77346993 |
| 71 | regulation of actin filament-based movement (GO:1903115) | 3.77099907 |
| 72 | cell communication by electrical coupling (GO:0010644) | 3.76772656 |
| 73 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.74354244 |
| 74 | innate immune response in mucosa (GO:0002227) | 3.73717779 |
| 75 | protein localization to synapse (GO:0035418) | 3.70826266 |
| 76 | dendritic spine morphogenesis (GO:0060997) | 3.65886140 |
| 77 | nuclear pore organization (GO:0006999) | 3.65756122 |
| 78 | cellular response to epinephrine stimulus (GO:0071872) | 3.65638329 |
| 79 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.65628337 |
| 80 | DNA unwinding involved in DNA replication (GO:0006268) | 3.64237065 |
| 81 | neuromuscular process controlling posture (GO:0050884) | 3.61780166 |
| 82 | peptidyl-lysine dimethylation (GO:0018027) | 3.61240643 |
| 83 | hemidesmosome assembly (GO:0031581) | 3.61221573 |
| 84 | renal filtration (GO:0097205) | 3.61200270 |
| 85 | cyclic nucleotide metabolic process (GO:0009187) | 3.60761297 |
| 86 | plasma membrane repair (GO:0001778) | 3.59893094 |
| 87 | snRNA processing (GO:0016180) | 3.59548823 |
| 88 | pyrimidine dimer repair (GO:0006290) | 3.56803731 |
| 89 | potassium ion import (GO:0010107) | 3.55168851 |
| 90 | nitrogen cycle metabolic process (GO:0071941) | 3.54669866 |
| 91 | response to epinephrine (GO:0071871) | 3.52732449 |
| 92 | fatty acid transmembrane transport (GO:1902001) | 3.51215491 |
| 93 | vesicle transport along microtubule (GO:0047496) | 3.47224140 |
| 94 | neurotransmitter transport (GO:0006836) | 3.46129814 |
| 95 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.45312436 |
| 96 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.44608359 |
| 97 | T cell mediated immunity (GO:0002456) | 3.44154134 |
| 98 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.40479809 |
| 99 | regulation of ARF protein signal transduction (GO:0032012) | 3.39540035 |
| 100 | snRNA metabolic process (GO:0016073) | 3.39492311 |
| 101 | long-term memory (GO:0007616) | 3.37051121 |
| 102 | cyclic nucleotide biosynthetic process (GO:0009190) | 3.36386638 |
| 103 | prepulse inhibition (GO:0060134) | 3.33077071 |
| 104 | cyclic purine nucleotide metabolic process (GO:0052652) | 3.33042772 |
| 105 | amino-acid betaine transport (GO:0015838) | 3.32857141 |
| 106 | carnitine transport (GO:0015879) | 3.32857141 |
| 107 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.30395283 |
| 108 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.29775992 |
| 109 | natural killer cell mediated immunity (GO:0002228) | 3.29775992 |
| 110 | chaperone-mediated protein folding (GO:0061077) | 3.29282534 |
| 111 | synaptic transmission, glutamatergic (GO:0035249) | 3.29176869 |
| 112 | pore complex assembly (GO:0046931) | 3.27172745 |
| 113 | neuron cell-cell adhesion (GO:0007158) | 3.25662836 |
| 114 | sarcomere organization (GO:0045214) | 3.25608488 |
| 115 | potassium ion homeostasis (GO:0055075) | 3.24597798 |
| 116 | regulation of neurotransmitter levels (GO:0001505) | 3.23104418 |
| 117 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.21676526 |
| 118 | response to caffeine (GO:0031000) | 3.20232092 |
| 119 | positive regulation of membrane potential (GO:0045838) | 3.19241514 |
| 120 | regulation of synaptic plasticity (GO:0048167) | 3.19083175 |
| 121 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.18628344 |
| 122 | homocysteine metabolic process (GO:0050667) | 3.18457684 |
| 123 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.17461106 |
| 124 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.16422818 |
| 125 | response to glucagon (GO:0033762) | 3.15383297 |
| 126 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.15096348 |
| 127 | positive regulation of cation channel activity (GO:2001259) | 3.14680002 |
| 128 | cellular sodium ion homeostasis (GO:0006883) | 3.13360054 |
| 129 | neuronal ion channel clustering (GO:0045161) | 3.12660806 |
| 130 | neuron-neuron synaptic transmission (GO:0007270) | 3.11711950 |
| 131 | cell communication involved in cardiac conduction (GO:0086065) | 3.10770391 |
| 132 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.08729400 |
| 133 | glutamate receptor signaling pathway (GO:0007215) | 3.08579918 |
| 134 | response to auditory stimulus (GO:0010996) | 3.08338270 |
| 135 | axon cargo transport (GO:0008088) | 3.07166064 |
| 136 | mating behavior (GO:0007617) | 3.06499120 |
| 137 | auditory behavior (GO:0031223) | 3.06055062 |
| 138 | membrane depolarization during action potential (GO:0086010) | 3.06043247 |
| 139 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.05965091 |
| 140 | cerebellar Purkinje cell layer development (GO:0021680) | 3.05481539 |
| 141 | positive regulation of icosanoid secretion (GO:0032305) | 3.05449949 |
| 142 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.05366252 |
| 143 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.03231715 |
| 144 | water transport (GO:0006833) | 3.02705994 |
| 145 | clathrin coat assembly (GO:0048268) | 3.02124905 |
| 146 | L-amino acid import (GO:0043092) | 3.01517415 |
| 147 | cAMP-mediated signaling (GO:0019933) | 3.01266461 |
| 148 | glycogen catabolic process (GO:0005980) | 3.01058677 |
| 149 | cardiac muscle hypertrophy (GO:0003300) | 3.00153719 |
| 150 | dendrite morphogenesis (GO:0048813) | 3.00089756 |
| 151 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.99312233 |
| 152 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.98445347 |
| 153 | interkinetic nuclear migration (GO:0022027) | 2.98077566 |
| 154 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.97462413 |
| 155 | regulation of neurotransmitter secretion (GO:0046928) | 2.97449207 |
| 156 | organelle transport along microtubule (GO:0072384) | 2.96548479 |
| 157 | neuromuscular process (GO:0050905) | 2.95663488 |
| 158 | synaptic vesicle endocytosis (GO:0048488) | 2.95100500 |
| 159 | transmission of nerve impulse (GO:0019226) | 2.94808460 |
| 160 | mucosal immune response (GO:0002385) | 2.93637156 |
| 161 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.93419402 |
| 162 | detection of calcium ion (GO:0005513) | 2.92580329 |
| 163 | membrane repolarization (GO:0086009) | 2.92038967 |
| 164 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.91701552 |
| 165 | regulation of postsynaptic membrane potential (GO:0060078) | 2.90942505 |
| 166 | cell migration in hindbrain (GO:0021535) | 2.87860080 |
| 167 | neuron recognition (GO:0008038) | 2.83890073 |
| 168 | regulation of neurotransmitter transport (GO:0051588) | 2.82685790 |
| 169 | antibacterial humoral response (GO:0019731) | 2.82342741 |
| 170 | striated muscle hypertrophy (GO:0014897) | 2.81022275 |
| 171 | positive regulation of synapse maturation (GO:0090129) | 2.80556433 |
| 172 | cardiac muscle cell action potential (GO:0086001) | 2.79898159 |
| 173 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.79285852 |
| 174 | positive regulation of neurotransmitter transport (GO:0051590) | 2.79189603 |
| 175 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.78940117 |
| 176 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.77551712 |
| 177 | membrane hyperpolarization (GO:0060081) | 2.76303053 |
| 178 | establishment of nucleus localization (GO:0040023) | 2.75001440 |
| 179 | cardiac muscle contraction (GO:0060048) | 2.74666009 |
| 180 | positive regulation of fatty acid transport (GO:2000193) | 2.74481276 |
| 181 | glucan catabolic process (GO:0009251) | 2.74423969 |
| 182 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.73445570 |
| 183 | regulation of vesicle fusion (GO:0031338) | 2.72528464 |
| 184 | dopamine receptor signaling pathway (GO:0007212) | 2.71770198 |
| 185 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.71434712 |
| 186 | regulation of ARF GTPase activity (GO:0032312) | 2.69993307 |
| 187 | membrane depolarization (GO:0051899) | 2.69690113 |
| 188 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.69183115 |
| 189 | positive regulation of potassium ion transport (GO:0043268) | 2.68915934 |
| 190 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.68736825 |
| 191 | striated muscle atrophy (GO:0014891) | 2.68426823 |
| 192 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.67601903 |
| 193 | adult walking behavior (GO:0007628) | 2.67237411 |
| 194 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.67037428 |
| 195 | long-term synaptic potentiation (GO:0060291) | 2.66854010 |
| 196 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 16.3182898 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 7.45260097 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.01114137 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.78057682 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.27637452 |
| 5 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.93666462 |
| 6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.83687831 |
| 7 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.73816453 |
| 8 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.73283012 |
| 9 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.68617287 |
| 10 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.68584336 |
| 11 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.64412560 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.60368712 |
| 13 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.55729660 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.55425595 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.53533787 |
| 16 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.53533787 |
| 17 | TP53_16413492_ChIP-PET_HCT116_Human | 2.52822670 |
| 18 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.46809117 |
| 19 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.45908184 |
| 20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.44373823 |
| 21 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.39872091 |
| 22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.19721512 |
| 23 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.17316639 |
| 24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.17225933 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.16688574 |
| 26 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.16040534 |
| 27 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.09683198 |
| 28 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.04951682 |
| 29 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.03995834 |
| 30 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 14.1885331 |
| 31 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.96158572 |
| 32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.94950804 |
| 33 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.92123718 |
| 34 | KDM2B_26808549_Chip-Seq_K562_Human | 1.91188491 |
| 35 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.88804306 |
| 36 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.87597713 |
| 37 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.82557290 |
| 38 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.81908982 |
| 39 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.78526422 |
| 40 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.77747044 |
| 41 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.73789240 |
| 42 | FUS_26573619_Chip-Seq_HEK293_Human | 1.70928922 |
| 43 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.69234280 |
| 44 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.67531966 |
| 45 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.67378808 |
| 46 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.67272276 |
| 47 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.62378560 |
| 48 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.62056352 |
| 49 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.54991959 |
| 50 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.54905314 |
| 51 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.54905314 |
| 52 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.54791136 |
| 53 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.53800561 |
| 54 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.48528497 |
| 55 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.44889937 |
| 56 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.44771791 |
| 57 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.43148388 |
| 58 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.42017112 |
| 59 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.42010937 |
| 60 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.40478016 |
| 61 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.39734693 |
| 62 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.39649552 |
| 63 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.39649552 |
| 64 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.38131830 |
| 65 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.34923087 |
| 66 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.34205395 |
| 67 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.34177256 |
| 68 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31735820 |
| 69 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.31043601 |
| 70 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.29155026 |
| 71 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.24021937 |
| 72 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.22168738 |
| 73 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.21948704 |
| 74 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.20149971 |
| 75 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.18848502 |
| 76 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.15795035 |
| 77 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.15323339 |
| 78 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15222979 |
| 79 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.15090401 |
| 80 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.13778108 |
| 81 | AR_19668381_ChIP-Seq_PC3_Human | 1.12919888 |
| 82 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.12675840 |
| 83 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.10598106 |
| 84 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.10530788 |
| 85 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.09342165 |
| 86 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.09158245 |
| 87 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09072192 |
| 88 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.08616705 |
| 89 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.08275970 |
| 90 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.07556351 |
| 91 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.06364903 |
| 92 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.05916522 |
| 93 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.04402942 |
| 94 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04113160 |
| 95 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.01664090 |
| 96 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00596934 |
| 97 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.99415209 |
| 98 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.98741105 |
| 99 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.97916635 |
| 100 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.97434398 |
| 101 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.97354346 |
| 102 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.97240015 |
| 103 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.96971766 |
| 104 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.94817954 |
| 105 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93951945 |
| 106 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.93764954 |
| 107 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93597770 |
| 108 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.93231816 |
| 109 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.93038787 |
| 110 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.92693427 |
| 111 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92566142 |
| 112 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.92394771 |
| 113 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.92300012 |
| 114 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.92074714 |
| 115 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.91934334 |
| 116 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.91906215 |
| 117 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.91851584 |
| 118 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91201673 |
| 119 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.90278143 |
| 120 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.90151979 |
| 121 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.90050043 |
| 122 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.89999566 |
| 123 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.89863485 |
| 124 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.89434874 |
| 125 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.89296349 |
| 126 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.88685989 |
| 127 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.87925297 |
| 128 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.86305639 |
| 129 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.85710129 |
| 130 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.85677750 |
| 131 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.85158010 |
| 132 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85093838 |
| 133 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.84581227 |
| 134 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.84411154 |
| 135 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.83429500 |
| 136 | RXR_22108803_ChIP-Seq_LS180_Human | 0.82544792 |
| 137 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.82311815 |
| 138 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.81902580 |
| 139 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81256782 |
| 140 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.81245539 |
| 141 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.81235516 |
| 142 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.80203512 |
| 143 | GATA1_19941826_ChIP-Seq_K562_Human | 0.79715747 |
| 144 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.79167782 |
| 145 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.79015172 |
| 146 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.78748722 |
| 147 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.78573817 |
| 148 | P68_20966046_ChIP-Seq_HELA_Human | 0.78510007 |
| 149 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.78182274 |
| 150 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.77742108 |
| 151 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.77713818 |
| 152 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.77222737 |
| 153 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.76810650 |
| 154 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.75731334 |
| 155 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.74878855 |
| 156 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.74650553 |
| 157 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.74631988 |
| 158 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73009528 |
| 159 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.72536001 |
| 160 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.67890016 |
| 161 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.66445444 |
| 162 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.65646379 |
| 163 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.65565275 |
| 164 | * MAF_26560356_Chip-Seq_TH1_Human | 0.65342715 |
| 165 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.65205964 |
| 166 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.61302424 |
| 167 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.61264271 |
| 168 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.60207647 |
| 169 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.59971881 |
| 170 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.59377753 |
| 171 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.59109506 |
| 172 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.58447517 |
| 173 | MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.57836860 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.86872181 |
| 2 | MP0002009_preneoplasia | 4.81024122 |
| 3 | MP0001661_extended_life_span | 4.71975712 |
| 4 | MP0010352_gastrointestinal_tract_polyps | 4.15129250 |
| 5 | MP0003880_abnormal_central_pattern | 4.11377120 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 4.08306915 |
| 7 | MP0004270_analgesia | 3.62911729 |
| 8 | MP0003950_abnormal_plasma_membrane | 3.19214554 |
| 9 | MP0009745_abnormal_behavioral_response | 3.14613884 |
| 10 | MP0002063_abnormal_learning/memory/cond | 3.10845389 |
| 11 | MP0002064_seizures | 3.05492834 |
| 12 | MP0002822_catalepsy | 3.04278702 |
| 13 | MP0009046_muscle_twitch | 2.82706309 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.77314449 |
| 15 | MP0001968_abnormal_touch/_nociception | 2.73511185 |
| 16 | MP0002166_altered_tumor_susceptibility | 2.67213037 |
| 17 | MP0004858_abnormal_nervous_system | 2.62426789 |
| 18 | MP0003646_muscle_fatigue | 2.55503265 |
| 19 | MP0002734_abnormal_mechanical_nocicepti | 2.51154437 |
| 20 | MP0008057_abnormal_DNA_replication | 2.48216974 |
| 21 | MP0002272_abnormal_nervous_system | 2.45090193 |
| 22 | MP0003221_abnormal_cardiomyocyte_apopto | 2.43057915 |
| 23 | MP0003329_amyloid_beta_deposits | 2.42041182 |
| 24 | MP0004185_abnormal_adipocyte_glucose | 2.42038215 |
| 25 | MP0002572_abnormal_emotion/affect_behav | 2.40337953 |
| 26 | MP0001486_abnormal_startle_reflex | 2.39664451 |
| 27 | MP0002909_abnormal_adrenal_gland | 2.37525004 |
| 28 | MP0000749_muscle_degeneration | 2.28314446 |
| 29 | MP0002733_abnormal_thermal_nociception | 2.17492521 |
| 30 | MP0009780_abnormal_chondrocyte_physiolo | 2.13799906 |
| 31 | MP0002269_muscular_atrophy | 2.07987284 |
| 32 | MP0002735_abnormal_chemical_nociception | 2.07604165 |
| 33 | MP0008569_lethality_at_weaning | 2.04184322 |
| 34 | MP0001970_abnormal_pain_threshold | 2.04056284 |
| 35 | MP0001501_abnormal_sleep_pattern | 2.03569467 |
| 36 | MP0002006_tumorigenesis | 2.02637387 |
| 37 | MP0004811_abnormal_neuron_physiology | 1.94855449 |
| 38 | MP0000750_abnormal_muscle_regeneration | 1.93771945 |
| 39 | MP0004885_abnormal_endolymph | 1.91499238 |
| 40 | MP0002736_abnormal_nociception_after | 1.91434363 |
| 41 | MP0004087_abnormal_muscle_fiber | 1.88318133 |
| 42 | MP0005666_abnormal_adipose_tissue | 1.85052168 |
| 43 | MP0001440_abnormal_grooming_behavior | 1.79398317 |
| 44 | MP0002332_abnormal_exercise_endurance | 1.76186143 |
| 45 | MP0003763_abnormal_thymus_physiology | 1.71824859 |
| 46 | MP0005451_abnormal_body_composition | 1.71127500 |
| 47 | MP0003283_abnormal_digestive_organ | 1.68096274 |
| 48 | MP0000579_abnormal_nail_morphology | 1.67975734 |
| 49 | MP0000955_abnormal_spinal_cord | 1.67666426 |
| 50 | MP0005171_absent_coat_pigmentation | 1.67342424 |
| 51 | MP0002067_abnormal_sensory_capabilities | 1.65686626 |
| 52 | MP0001984_abnormal_olfaction | 1.65259301 |
| 53 | MP0005375_adipose_tissue_phenotype | 1.65188454 |
| 54 | MP0005083_abnormal_biliary_tract | 1.61536591 |
| 55 | MP0003633_abnormal_nervous_system | 1.61528439 |
| 56 | MP0002184_abnormal_innervation | 1.58290348 |
| 57 | MP0008961_abnormal_basal_metabolism | 1.54355490 |
| 58 | MP0000733_abnormal_muscle_development | 1.52988416 |
| 59 | MP0004381_abnormal_hair_follicle | 1.52771935 |
| 60 | MP0005167_abnormal_blood-brain_barrier | 1.51271535 |
| 61 | MP0005076_abnormal_cell_differentiation | 1.49799458 |
| 62 | MP0003075_altered_response_to | 1.49214572 |
| 63 | MP0000383_abnormal_hair_follicle | 1.47836509 |
| 64 | MP0010678_abnormal_skin_adnexa | 1.47432754 |
| 65 | MP0002557_abnormal_social/conspecific_i | 1.46505181 |
| 66 | MP0005330_cardiomyopathy | 1.45973169 |
| 67 | MP0004924_abnormal_behavior | 1.45907928 |
| 68 | MP0005386_behavior/neurological_phenoty | 1.45907928 |
| 69 | MP0000751_myopathy | 1.44218648 |
| 70 | MP0003705_abnormal_hypodermis_morpholog | 1.43930430 |
| 71 | MP0005275_abnormal_skin_tensile | 1.43455931 |
| 72 | MP0000778_abnormal_nervous_system | 1.39630683 |
| 73 | MP0002066_abnormal_motor_capabilities/c | 1.39349940 |
| 74 | MP0000759_abnormal_skeletal_muscle | 1.37651027 |
| 75 | MP0003690_abnormal_glial_cell | 1.37583343 |
| 76 | MP0003453_abnormal_keratinocyte_physiol | 1.37016086 |
| 77 | MP0002877_abnormal_melanocyte_morpholog | 1.36532175 |
| 78 | MP0003879_abnormal_hair_cell | 1.36190394 |
| 79 | MP0010234_abnormal_vibrissa_follicle | 1.35206120 |
| 80 | MP0002882_abnormal_neuron_morphology | 1.33761956 |
| 81 | MP0005623_abnormal_meninges_morphology | 1.32051972 |
| 82 | MP0003631_nervous_system_phenotype | 1.27402898 |
| 83 | MP0000920_abnormal_myelination | 1.26602245 |
| 84 | MP0005647_abnormal_sex_gland | 1.26430724 |
| 85 | MP0000604_amyloidosis | 1.24956305 |
| 86 | MP0003172_abnormal_lysosome_physiology | 1.21617790 |
| 87 | MP0008438_abnormal_cutaneous_collagen | 1.20464409 |
| 88 | MP0002106_abnormal_muscle_physiology | 1.19540761 |
| 89 | MP0003634_abnormal_glial_cell | 1.19153476 |
| 90 | MP0005646_abnormal_pituitary_gland | 1.16536682 |
| 91 | MP0005165_increased_susceptibility_to | 1.16292043 |
| 92 | MP0000013_abnormal_adipose_tissue | 1.13342927 |
| 93 | MP0008874_decreased_physiological_sensi | 1.10881067 |
| 94 | MP0001216_abnormal_epidermal_layer | 1.04196101 |
| 95 | MP0002229_neurodegeneration | 1.04032282 |
| 96 | MP0010630_abnormal_cardiac_muscle | 1.02227417 |
| 97 | MP0001243_abnormal_dermal_layer | 1.01022447 |
| 98 | MP0000747_muscle_weakness | 1.00217290 |
| 99 | MP0002152_abnormal_brain_morphology | 1.00073259 |
| 100 | MP0005670_abnormal_white_adipose | 0.99780781 |
| 101 | MP0006276_abnormal_autonomic_nervous | 0.99764413 |
| 102 | MP0003787_abnormal_imprinting | 0.99622506 |
| 103 | MP0005645_abnormal_hypothalamus_physiol | 0.98666484 |
| 104 | MP0008872_abnormal_physiological_respon | 0.98468596 |
| 105 | MP0002972_abnormal_cardiac_muscle | 0.97817902 |
| 106 | MP0004142_abnormal_muscle_tone | 0.97671481 |
| 107 | MP0004130_abnormal_muscle_cell | 0.96034432 |
| 108 | MP0001986_abnormal_taste_sensitivity | 0.95204358 |
| 109 | MP0001177_atelectasis | 0.94602562 |
| 110 | MP0004808_abnormal_hematopoietic_stem | 0.93167638 |
| 111 | MP0001502_abnormal_circadian_rhythm | 0.92233644 |
| 112 | MP0004085_abnormal_heartbeat | 0.90530064 |
| 113 | MP0002971_abnormal_brown_adipose | 0.90204277 |
| 114 | MP0002060_abnormal_skin_morphology | 0.90037249 |
| 115 | MP0000377_abnormal_hair_follicle | 0.89550717 |
| 116 | MP0003122_maternal_imprinting | 0.88780715 |
| 117 | MP0003183_abnormal_peptide_metabolism | 0.88297649 |
| 118 | MP0003632_abnormal_nervous_system | 0.86819248 |
| 119 | MP0004510_myositis | 0.86470378 |
| 120 | MP0003137_abnormal_impulse_conducting | 0.84897171 |
| 121 | MP0002069_abnormal_eating/drinking_beha | 0.84535612 |
| 122 | MP0000569_abnormal_digit_pigmentation | 0.84050899 |
| 123 | MP0005369_muscle_phenotype | 0.82693040 |
| 124 | MP0005535_abnormal_body_temperature | 0.80192926 |
| 125 | MP0004145_abnormal_muscle_electrophysio | 0.79928781 |
| 126 | MP0001958_emphysema | 0.77957091 |
| 127 | MP0001348_abnormal_lacrimal_gland | 0.77956164 |
| 128 | MP0000427_abnormal_hair_cycle | 0.77748239 |
| 129 | MP0002837_dystrophic_cardiac_calcinosis | 0.75516525 |
| 130 | MP0009697_abnormal_copulation | 0.74691838 |
| 131 | MP0010094_abnormal_chromosome_stability | 0.74637124 |
| 132 | MP0004233_abnormal_muscle_weight | 0.74548127 |
| 133 | MP0000490_abnormal_crypts_of | 0.74385631 |
| 134 | MP0009115_abnormal_fat_cell | 0.74150234 |
| 135 | MP0010307_abnormal_tumor_latency | 0.73092926 |
| 136 | MP0004484_altered_response_of | 0.72847117 |
| 137 | MP0001905_abnormal_dopamine_level | 0.72665872 |
| 138 | MP0004084_abnormal_cardiac_muscle | 0.70956243 |
| 139 | MP0005166_decreased_susceptibility_to | 0.70829892 |
| 140 | MP0004036_abnormal_muscle_relaxation | 0.70545285 |
| 141 | MP0003303_peritoneal_inflammation | 0.70454487 |
| 142 | MP0005620_abnormal_muscle_contractility | 0.70335830 |
| 143 | MP0004215_abnormal_myocardial_fiber | 0.69081620 |
| 144 | MP0001299_abnormal_eye_distance/ | 0.67929467 |
| 145 | MP0004043_abnormal_pH_regulation | 0.67358184 |
| 146 | MP0000003_abnormal_adipose_tissue | 0.66672248 |
| 147 | MP0005394_taste/olfaction_phenotype | 0.66595192 |
| 148 | MP0005499_abnormal_olfactory_system | 0.66595192 |
| 149 | MP0003786_premature_aging | 0.66538344 |
| 150 | MP0002396_abnormal_hematopoietic_system | 0.66403241 |
| 151 | MP0006138_congestive_heart_failure | 0.65321613 |
| 152 | MP0002090_abnormal_vision | 0.65044752 |
| 153 | MP0001485_abnormal_pinna_reflex | 0.65021099 |
| 154 | MP0005266_abnormal_metabolism | 0.64721505 |
| 155 | MP0003091_abnormal_cell_migration | 0.64235889 |
| 156 | MP0005023_abnormal_wound_healing | 0.61463131 |
| 157 | MP0004134_abnormal_chest_morphology | 0.61371702 |
| 158 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.59447209 |
| 159 | MP0001873_stomach_inflammation | 0.59232737 |
| 160 | MP0003045_fibrosis | 0.58935536 |
| 161 | MP0003191_abnormal_cellular_cholesterol | 0.57555198 |
| 162 | MP0001943_abnormal_respiration | 0.57026491 |
| 163 | MP0002752_abnormal_somatic_nervous | 0.55614961 |
| 164 | MP0000367_abnormal_coat/_hair | 0.54485920 |
| 165 | MP0000534_abnormal_ureter_morphology | 0.53879640 |
| 166 | MP0008058_abnormal_DNA_repair | 0.53835092 |
| 167 | MP0004742_abnormal_vestibular_system | 0.53827313 |
| 168 | MP0001664_abnormal_digestion | 0.53622869 |
| 169 | MP0001529_abnormal_vocalization | 0.53564454 |
| 170 | MP0003656_abnormal_erythrocyte_physiolo | 0.51131648 |
| 171 | MP0010155_abnormal_intestine_physiology | 0.47453243 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 6.90115035 |
| 2 | Focal motor seizures (HP:0011153) | 5.42560560 |
| 3 | Milia (HP:0001056) | 5.09364401 |
| 4 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 5.01772661 |
| 5 | Short 4th metacarpal (HP:0010044) | 5.01772661 |
| 6 | Visual hallucinations (HP:0002367) | 4.87657980 |
| 7 | Right ventricular cardiomyopathy (HP:0011663) | 4.77127326 |
| 8 | Supranuclear gaze palsy (HP:0000605) | 4.69003664 |
| 9 | Focal seizures (HP:0007359) | 4.62786987 |
| 10 | Increased circulating renin level (HP:0000848) | 4.47870982 |
| 11 | Abnormality of the parietal bone (HP:0002696) | 4.33763078 |
| 12 | Action tremor (HP:0002345) | 4.21694589 |
| 13 | Ankle clonus (HP:0011448) | 4.20728841 |
| 14 | Short phalanx of the thumb (HP:0009660) | 4.18352184 |
| 15 | Deformed sella turcica (HP:0002681) | 4.03952609 |
| 16 | Medulloblastoma (HP:0002885) | 4.03396470 |
| 17 | Hyporeflexia of lower limbs (HP:0002600) | 3.87261197 |
| 18 | Abnormality of the 4th metacarpal (HP:0010012) | 3.80874048 |
| 19 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 3.74846020 |
| 20 | Down-sloping shoulders (HP:0200021) | 3.65815524 |
| 21 | Ventricular tachycardia (HP:0004756) | 3.62854870 |
| 22 | Myoglobinuria (HP:0002913) | 3.61930465 |
| 23 | Entropion (HP:0000621) | 3.53944703 |
| 24 | Ventricular fibrillation (HP:0001663) | 3.49151161 |
| 25 | Depression (HP:0000716) | 3.45052775 |
| 26 | Increased connective tissue (HP:0009025) | 3.40273313 |
| 27 | Postural instability (HP:0002172) | 3.33381964 |
| 28 | Atonic seizures (HP:0010819) | 3.28397798 |
| 29 | Papilledema (HP:0001085) | 3.28095977 |
| 30 | Neoplasm of the oral cavity (HP:0100649) | 3.26364025 |
| 31 | Mutism (HP:0002300) | 3.21459043 |
| 32 | Progressive cerebellar ataxia (HP:0002073) | 3.20668616 |
| 33 | Abnormality of the sella turcica (HP:0002679) | 3.19073926 |
| 34 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 3.18823070 |
| 35 | Abnormality of the lower motor neuron (HP:0002366) | 3.16297366 |
| 36 | Generalized tonic-clonic seizures (HP:0002069) | 3.14573914 |
| 37 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.14068089 |
| 38 | Urinary urgency (HP:0000012) | 3.13198318 |
| 39 | Abnormal auditory evoked potentials (HP:0006958) | 3.12181529 |
| 40 | Absence seizures (HP:0002121) | 3.11388127 |
| 41 | Insomnia (HP:0100785) | 3.11347106 |
| 42 | Neoplasm of striated muscle (HP:0009728) | 3.10090609 |
| 43 | Torticollis (HP:0000473) | 3.05513120 |
| 44 | Exercise-induced myalgia (HP:0003738) | 3.04497097 |
| 45 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.04471365 |
| 46 | Epileptic encephalopathy (HP:0200134) | 3.01508258 |
| 47 | Supernumerary ribs (HP:0005815) | 2.93457592 |
| 48 | Neurofibrillary tangles (HP:0002185) | 2.92948820 |
| 49 | Poor eye contact (HP:0000817) | 2.91754688 |
| 50 | Difficulty running (HP:0009046) | 2.91753590 |
| 51 | Hemiplegia (HP:0002301) | 2.90668357 |
| 52 | Febrile seizures (HP:0002373) | 2.90373196 |
| 53 | Annular pancreas (HP:0001734) | 2.89198221 |
| 54 | Frequent falls (HP:0002359) | 2.85876377 |
| 55 | Bundle branch block (HP:0011710) | 2.85231746 |
| 56 | Cerebral inclusion bodies (HP:0100314) | 2.84540944 |
| 57 | Generalized muscle weakness (HP:0003324) | 2.84525389 |
| 58 | Impaired social interactions (HP:0000735) | 2.83830317 |
| 59 | Abnormal social behavior (HP:0012433) | 2.83830317 |
| 60 | Dysmetria (HP:0001310) | 2.81482529 |
| 61 | Insidious onset (HP:0003587) | 2.77564801 |
| 62 | Termporal pattern (HP:0011008) | 2.77564801 |
| 63 | Abnormal ossification of hand bones (HP:0005921) | 2.77507498 |
| 64 | Anxiety (HP:0000739) | 2.77044263 |
| 65 | Dialeptic seizures (HP:0011146) | 2.75455205 |
| 66 | Spastic gait (HP:0002064) | 2.74813970 |
| 67 | Intention tremor (HP:0002080) | 2.74202708 |
| 68 | Short nail (HP:0001799) | 2.72620114 |
| 69 | Fetal akinesia sequence (HP:0001989) | 2.71073358 |
| 70 | Abnormal eating behavior (HP:0100738) | 2.69489769 |
| 71 | Abnormal hand bone ossification (HP:0010660) | 2.68464111 |
| 72 | Focal dystonia (HP:0004373) | 2.66446589 |
| 73 | Dysdiadochokinesis (HP:0002075) | 2.66234697 |
| 74 | Supernumerary bones of the axial skeleton (HP:0009144) | 2.65157376 |
| 75 | Basal cell carcinoma (HP:0002671) | 2.64465480 |
| 76 | Rapidly progressive (HP:0003678) | 2.63159720 |
| 77 | Sensory axonal neuropathy (HP:0003390) | 2.58973817 |
| 78 | Truncal ataxia (HP:0002078) | 2.56453808 |
| 79 | Craniofacial dystonia (HP:0012179) | 2.54507364 |
| 80 | Alkalosis (HP:0001948) | 2.51612081 |
| 81 | Megalencephaly (HP:0001355) | 2.51132160 |
| 82 | Pointed chin (HP:0000307) | 2.48292083 |
| 83 | Hypokalemic alkalosis (HP:0001949) | 2.47563497 |
| 84 | Resting tremor (HP:0002322) | 2.46185589 |
| 85 | Bradykinesia (HP:0002067) | 2.44257200 |
| 86 | Hyperacusis (HP:0010780) | 2.43014759 |
| 87 | Lower limb muscle weakness (HP:0007340) | 2.39613569 |
| 88 | Exercise-induced muscle cramps (HP:0003710) | 2.37611763 |
| 89 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.37284778 |
| 90 | Prominent nose (HP:0000448) | 2.35627842 |
| 91 | Dysmetric saccades (HP:0000641) | 2.35524675 |
| 92 | Peripheral hypomyelination (HP:0007182) | 2.34691191 |
| 93 | Pheochromocytoma (HP:0002666) | 2.33267472 |
| 94 | Colitis (HP:0002583) | 2.32292519 |
| 95 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.29535583 |
| 96 | Osteolytic defects of the hand bones (HP:0009699) | 2.29535583 |
| 97 | Scanning speech (HP:0002168) | 2.28575296 |
| 98 | Genetic anticipation (HP:0003743) | 2.28218730 |
| 99 | Calf muscle hypertrophy (HP:0008981) | 2.25443897 |
| 100 | Neuronal loss in central nervous system (HP:0002529) | 2.24167228 |
| 101 | Amblyopia (HP:0000646) | 2.24133924 |
| 102 | Clonus (HP:0002169) | 2.23152835 |
| 103 | Abnormality of the calf musculature (HP:0001430) | 2.21654412 |
| 104 | Tubular atrophy (HP:0000092) | 2.21331321 |
| 105 | Rhabdomyolysis (HP:0003201) | 2.20869202 |
| 106 | Abnormality of binocular vision (HP:0011514) | 2.20050845 |
| 107 | Diplopia (HP:0000651) | 2.20050845 |
| 108 | Apathy (HP:0000741) | 2.18757826 |
| 109 | Broad-based gait (HP:0002136) | 2.18649051 |
| 110 | Gaze-evoked nystagmus (HP:0000640) | 2.18126313 |
| 111 | Heterotopia (HP:0002282) | 2.17651081 |
| 112 | Menstrual irregularities (HP:0000858) | 2.16454603 |
| 113 | Hamartoma (HP:0010566) | 2.16408602 |
| 114 | Abnormal atrioventricular conduction (HP:0005150) | 2.16273523 |
| 115 | Paralysis (HP:0003470) | 2.15317999 |
| 116 | Impaired smooth pursuit (HP:0007772) | 2.13956048 |
| 117 | Abnormality of the corticospinal tract (HP:0002492) | 2.13348365 |
| 118 | Hypercortisolism (HP:0001578) | 2.13159454 |
| 119 | Cerebellar dysplasia (HP:0007033) | 2.11795877 |
| 120 | EMG: myopathic abnormalities (HP:0003458) | 2.11384684 |
| 121 | Limb dystonia (HP:0002451) | 2.10591554 |
| 122 | Mild short stature (HP:0003502) | 2.10566812 |
| 123 | Distal upper limb amyotrophy (HP:0007149) | 2.09961751 |
| 124 | Upper limb amyotrophy (HP:0009129) | 2.09961751 |
| 125 | Progressive inability to walk (HP:0002505) | 2.09304950 |
| 126 | Abnormal EKG (HP:0003115) | 2.08710032 |
| 127 | Lower limb amyotrophy (HP:0007210) | 2.08072731 |
| 128 | Rigidity (HP:0002063) | 2.07945545 |
| 129 | Abnormality of DNA repair (HP:0003254) | 2.07311368 |
| 130 | Stereotypic behavior (HP:0000733) | 2.06950124 |
| 131 | Hemiparesis (HP:0001269) | 2.06097569 |
| 132 | Duplicated collecting system (HP:0000081) | 2.05848311 |
| 133 | Ureteral duplication (HP:0000073) | 2.04385407 |
| 134 | Onion bulb formation (HP:0003383) | 2.02090358 |
| 135 | Abnormality of nail color (HP:0100643) | 2.00886174 |
| 136 | Distal lower limb amyotrophy (HP:0008944) | 2.00673300 |
| 137 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.00483859 |
| 138 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.00399848 |
| 139 | Subaortic stenosis (HP:0001682) | 2.00399848 |
| 140 | Flattened epiphyses (HP:0003071) | 2.00352743 |
| 141 | Prolonged QT interval (HP:0001657) | 1.99617765 |
| 142 | Hammertoe (HP:0001765) | 1.98919835 |
| 143 | Overriding aorta (HP:0002623) | 1.98128902 |
| 144 | Broad face (HP:0000283) | 1.97792784 |
| 145 | Partial agenesis of the corpus callosum (HP:0001338) | 1.97391880 |
| 146 | Elfin facies (HP:0004428) | 1.95603899 |
| 147 | Decreased lacrimation (HP:0000633) | 1.95439113 |
| 148 | Diminished motivation (HP:0000745) | 1.94923820 |
| 149 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.94280408 |
| 150 | Ventricular arrhythmia (HP:0004308) | 1.94185741 |
| 151 | Lipoatrophy (HP:0100578) | 1.94041531 |
| 152 | Atrial fibrillation (HP:0005110) | 1.93681096 |
| 153 | Interstitial pulmonary disease (HP:0006530) | 1.93330867 |
| 154 | Abnormality of saccadic eye movements (HP:0000570) | 1.91797857 |
| 155 | Impaired vibratory sensation (HP:0002495) | 1.91050952 |
| 156 | Ankyloglossia (HP:0010296) | 1.89430460 |
| 157 | Neuroendocrine neoplasm (HP:0100634) | 1.87228957 |
| 158 | Achilles tendon contracture (HP:0001771) | 1.87035469 |
| 159 | Status epilepticus (HP:0002133) | 1.86487390 |
| 160 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.86469418 |
| 161 | Sudden death (HP:0001699) | 1.86099311 |
| 162 | Anosmia (HP:0000458) | 1.84979904 |
| 163 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.84183682 |
| 164 | Dilated cardiomyopathy (HP:0001644) | 1.83980307 |
| 165 | Poikiloderma (HP:0001029) | 1.83639570 |
| 166 | Syncope (HP:0001279) | 1.82419692 |
| 167 | Heart block (HP:0012722) | 1.81957490 |
| 168 | Neoplasm of the heart (HP:0100544) | 1.81921338 |
| 169 | Abnormality of the periventricular white matter (HP:0002518) | 1.81765760 |
| 170 | Skin pits (HP:0100276) | 1.81580677 |
| 171 | Lower limb asymmetry (HP:0100559) | 1.81155414 |
| 172 | Macroorchidism (HP:0000053) | 1.80970434 |
| 173 | Muscle fiber splitting (HP:0003555) | 1.80873088 |
| 174 | Postural tremor (HP:0002174) | 1.80127686 |
| 175 | Hypoplasia of the iris (HP:0007676) | 1.79531889 |
| 176 | Agitation (HP:0000713) | 1.78928491 |
| 177 | Nemaline bodies (HP:0003798) | 1.78830381 |
| 178 | Tetany (HP:0001281) | 1.78771537 |
| 179 | Abnormality of cochlea (HP:0000375) | 1.78229213 |
| 180 | Abnormality of the renal collecting system (HP:0004742) | 1.75701525 |
| 181 | Deep philtrum (HP:0002002) | 1.75176691 |
| 182 | Fair hair (HP:0002286) | 1.74283310 |
| 183 | Muscular dystrophy (HP:0003560) | 1.74107093 |
| 184 | Natal tooth (HP:0000695) | 1.72956029 |
| 185 | Abnormality of the epiphyses of the hand (HP:0005924) | 1.70377644 |
| 186 | Blue irides (HP:0000635) | 1.70258542 |
| 187 | Progressive sensorineural hearing impairment (HP:0000408) | 1.70217762 |
| 188 | EMG: neuropathic changes (HP:0003445) | 1.70184334 |
| 189 | Truncal obesity (HP:0001956) | 1.69617118 |
| 190 | Decreased motor nerve conduction velocity (HP:0003431) | 1.69297309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 4.28571429 |
| 2 | STK39 | 4.25654375 |
| 3 | NTRK3 | 3.69259288 |
| 4 | EPHA4 | 3.21534429 |
| 5 | KSR2 | 2.98168451 |
| 6 | OXSR1 | 2.95028663 |
| 7 | NEK9 | 2.71561413 |
| 8 | PRKD3 | 2.68626325 |
| 9 | MST1R | 2.66534573 |
| 10 | MINK1 | 2.60056985 |
| 11 | ZAK | 2.53327001 |
| 12 | TLK1 | 2.51615168 |
| 13 | PAK6 | 2.47599358 |
| 14 | MARK1 | 2.42733172 |
| 15 | MAP3K4 | 2.42143139 |
| 16 | NTRK1 | 2.33674622 |
| 17 | DAPK2 | 2.32780925 |
| 18 | OBSCN | 2.20449129 |
| 19 | CAMKK1 | 2.17918051 |
| 20 | LMTK2 | 2.01528246 |
| 21 | PDK2 | 2.00932860 |
| 22 | STK38 | 1.75928736 |
| 23 | MAP3K2 | 1.75481452 |
| 24 | NTRK2 | 1.74551518 |
| 25 | MAP2K4 | 1.61548119 |
| 26 | PHKG2 | 1.57208935 |
| 27 | PHKG1 | 1.57208935 |
| 28 | TRIB3 | 1.52086946 |
| 29 | ALK | 1.48360320 |
| 30 | EPHA3 | 1.46465900 |
| 31 | RPS6KA5 | 1.45768959 |
| 32 | TYRO3 | 1.45064672 |
| 33 | CDK5 | 1.44178681 |
| 34 | TAOK1 | 1.41087217 |
| 35 | MAP2K7 | 1.38160984 |
| 36 | LATS2 | 1.31733774 |
| 37 | RET | 1.31280573 |
| 38 | GRK5 | 1.29260390 |
| 39 | RIPK4 | 1.28777306 |
| 40 | UHMK1 | 1.28086630 |
| 41 | MAP3K12 | 1.27337751 |
| 42 | PDGFRB | 1.26148949 |
| 43 | RIPK1 | 1.25126410 |
| 44 | SIK2 | 1.24081154 |
| 45 | PRKCH | 1.23815967 |
| 46 | NEK1 | 1.20590879 |
| 47 | ARAF | 1.20178569 |
| 48 | FES | 1.19175691 |
| 49 | KSR1 | 1.17321394 |
| 50 | MAP3K13 | 1.11525267 |
| 51 | DAPK1 | 1.10528967 |
| 52 | ABL2 | 1.08897950 |
| 53 | MAPKAPK5 | 1.07448857 |
| 54 | MET | 1.06124283 |
| 55 | TTN | 1.04769592 |
| 56 | NEK6 | 1.03921991 |
| 57 | PKN2 | 1.03609294 |
| 58 | MAP3K6 | 1.02898975 |
| 59 | HCK | 1.00260463 |
| 60 | PINK1 | 1.00166745 |
| 61 | RPS6KB2 | 0.98620624 |
| 62 | CDC7 | 0.97661744 |
| 63 | STK11 | 0.97481691 |
| 64 | MAP3K1 | 0.95370547 |
| 65 | WNK1 | 0.94037266 |
| 66 | PAK3 | 0.93972038 |
| 67 | PKN1 | 0.90813193 |
| 68 | CDK19 | 0.88694251 |
| 69 | TRPM7 | 0.87523906 |
| 70 | PBK | 0.87391775 |
| 71 | MARK2 | 0.86337412 |
| 72 | SCYL2 | 0.86315296 |
| 73 | SGK223 | 0.85821015 |
| 74 | SGK494 | 0.85821015 |
| 75 | CAMK1 | 0.85161337 |
| 76 | PRKCG | 0.85028363 |
| 77 | PDPK1 | 0.83838469 |
| 78 | CCNB1 | 0.83036024 |
| 79 | PRKAA2 | 0.81735107 |
| 80 | PDK1 | 0.80893426 |
| 81 | MAP3K7 | 0.80420464 |
| 82 | CDK15 | 0.79451765 |
| 83 | CDC42BPA | 0.78938437 |
| 84 | TNK2 | 0.78079765 |
| 85 | CDK14 | 0.76553730 |
| 86 | SGK3 | 0.76103095 |
| 87 | CDK18 | 0.75810284 |
| 88 | PDGFRA | 0.75523508 |
| 89 | CAMKK2 | 0.74916964 |
| 90 | MAPK12 | 0.73969181 |
| 91 | ICK | 0.73632585 |
| 92 | CDK12 | 0.72016209 |
| 93 | CDK11A | 0.69224452 |
| 94 | BMX | 0.68589966 |
| 95 | MAPK11 | 0.67220876 |
| 96 | LIMK1 | 0.66558793 |
| 97 | RAF1 | 0.64793507 |
| 98 | CAMK2B | 0.64100354 |
| 99 | CDK6 | 0.64083987 |
| 100 | CAMK2A | 0.62522541 |
| 101 | DMPK | 0.62468632 |
| 102 | PRKAA1 | 0.62053468 |
| 103 | FGFR3 | 0.60915269 |
| 104 | MAPK13 | 0.59153729 |
| 105 | FER | 0.59025717 |
| 106 | PNCK | 0.59015627 |
| 107 | PLK2 | 0.58248224 |
| 108 | BLK | 0.57708776 |
| 109 | PTK2B | 0.57395408 |
| 110 | PRPF4B | 0.56724300 |
| 111 | CAMK1G | 0.56618809 |
| 112 | STK4 | 0.55582074 |
| 113 | AURKB | 0.55362213 |
| 114 | MAP2K1 | 0.54512676 |
| 115 | DAPK3 | 0.54186543 |
| 116 | RPS6KA2 | 0.53690426 |
| 117 | SGK1 | 0.53331277 |
| 118 | BTK | 0.52874628 |
| 119 | FYN | 0.52511487 |
| 120 | AURKA | 0.51815652 |
| 121 | MUSK | 0.50883084 |
| 122 | CAMK2G | 0.50237260 |
| 123 | PRKD1 | 0.49969783 |
| 124 | PRKG2 | 0.49629009 |
| 125 | CSNK1G2 | 0.49532064 |
| 126 | PRKCZ | 0.49500181 |
| 127 | AKT3 | 0.49478389 |
| 128 | RPS6KA3 | 0.49437916 |
| 129 | MAPK10 | 0.48127975 |
| 130 | DDR2 | 0.47442939 |
| 131 | WNK4 | 0.47183149 |
| 132 | ROCK2 | 0.46373610 |
| 133 | CAMK4 | 0.44755016 |
| 134 | BRSK1 | 0.44704840 |
| 135 | CAMK2D | 0.43406351 |
| 136 | RPS6KB1 | 0.42925075 |
| 137 | SGK2 | 0.41294566 |
| 138 | EEF2K | 0.40970002 |
| 139 | MTOR | 0.40647762 |
| 140 | ROCK1 | 0.40415744 |
| 141 | JAK2 | 0.38336183 |
| 142 | CAMK1D | 0.35463575 |
| 143 | AKT2 | 0.32402231 |
| 144 | RPS6KA4 | 0.32195523 |
| 145 | BRD4 | 0.31878873 |
| 146 | PIM1 | 0.28933903 |
| 147 | NME2 | 0.28708235 |
| 148 | MAPK4 | 0.27498026 |
| 149 | NLK | 0.26375457 |
| 150 | VRK1 | 0.25974524 |
| 151 | LATS1 | 0.25473853 |
| 152 | BRAF | 0.25161214 |
| 153 | MAPK9 | 0.24963933 |
| 154 | MAP3K8 | 0.23051755 |
| 155 | EPHA2 | 0.22635681 |
| 156 | JAK1 | 0.20039545 |
| 157 | MAPKAPK3 | 0.19858881 |
| 158 | CDK7 | 0.18321262 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 6.00336289 |
| 2 | Alcoholism_Homo sapiens_hsa05034 | 4.35320326 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.02217562 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 3.02162672 |
| 5 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.54210407 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.43759395 |
| 7 | Nicotine addiction_Homo sapiens_hsa05033 | 2.40482825 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.33195802 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 2.26379471 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.18137908 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.06477019 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 2.03354778 |
| 13 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.99333817 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 1.98213348 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.96572827 |
| 16 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.93765877 |
| 17 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.93021820 |
| 18 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.89912483 |
| 19 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.84475783 |
| 20 | Insulin secretion_Homo sapiens_hsa04911 | 1.81262061 |
| 21 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.79003964 |
| 22 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.77982578 |
| 23 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.70900415 |
| 24 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.66635073 |
| 25 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.61112112 |
| 26 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.60694888 |
| 27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.46418640 |
| 28 | Cocaine addiction_Homo sapiens_hsa05030 | 1.43523506 |
| 29 | Renin secretion_Homo sapiens_hsa04924 | 1.42902042 |
| 30 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.42136377 |
| 31 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.33378378 |
| 32 | Gap junction_Homo sapiens_hsa04540 | 1.32859521 |
| 33 | Taste transduction_Homo sapiens_hsa04742 | 1.30498980 |
| 34 | Long-term depression_Homo sapiens_hsa04730 | 1.25186342 |
| 35 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.25172423 |
| 36 | Glioma_Homo sapiens_hsa05214 | 1.23815975 |
| 37 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.23784715 |
| 38 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.23192678 |
| 39 | Insulin resistance_Homo sapiens_hsa04931 | 1.22778781 |
| 40 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.21736302 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.18077096 |
| 42 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.17579777 |
| 43 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.15731070 |
| 44 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.15059281 |
| 45 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.11945573 |
| 46 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.09578980 |
| 47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.07734969 |
| 48 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.05660840 |
| 49 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.00832720 |
| 50 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.98653394 |
| 51 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.98455371 |
| 52 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.98344392 |
| 53 | Axon guidance_Homo sapiens_hsa04360 | 0.94946549 |
| 54 | Melanogenesis_Homo sapiens_hsa04916 | 0.94701659 |
| 55 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.94697138 |
| 56 | Colorectal cancer_Homo sapiens_hsa05210 | 0.94284825 |
| 57 | DNA replication_Homo sapiens_hsa03030 | 0.93337132 |
| 58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.90312151 |
| 59 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.89967465 |
| 60 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.89137917 |
| 61 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.88666506 |
| 62 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.88516775 |
| 63 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.87357357 |
| 64 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.87123958 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.86355557 |
| 66 | Bile secretion_Homo sapiens_hsa04976 | 0.86008304 |
| 67 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.85695286 |
| 68 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.84274377 |
| 69 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.81809499 |
| 70 | Endocytosis_Homo sapiens_hsa04144 | 0.81128171 |
| 71 | Focal adhesion_Homo sapiens_hsa04510 | 0.78373411 |
| 72 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.77276056 |
| 73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75891200 |
| 74 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.75571173 |
| 75 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.72113648 |
| 76 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.71938009 |
| 77 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68338338 |
| 78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67935400 |
| 79 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.67898105 |
| 80 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.67865701 |
| 81 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.67365396 |
| 82 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.66747316 |
| 83 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.66187018 |
| 84 | Viral myocarditis_Homo sapiens_hsa05416 | 0.65571393 |
| 85 | Endometrial cancer_Homo sapiens_hsa05213 | 0.64753283 |
| 86 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63841776 |
| 87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63718807 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63615623 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61484368 |
| 90 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.59938234 |
| 91 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.59099448 |
| 92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.58980514 |
| 93 | Pathways in cancer_Homo sapiens_hsa05200 | 0.58562457 |
| 94 | Lysine degradation_Homo sapiens_hsa00310 | 0.58192280 |
| 95 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.58021306 |
| 96 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.56364867 |
| 97 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.56347807 |
| 98 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.55703915 |
| 99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55343790 |
| 100 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55095551 |
| 101 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.54528333 |
| 102 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.54474428 |
| 103 | Prion diseases_Homo sapiens_hsa05020 | 0.54350631 |
| 104 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53926473 |
| 105 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53494661 |
| 106 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.53178038 |
| 107 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.52867208 |
| 108 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.52634029 |
| 109 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.51461761 |
| 110 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.48724290 |
| 111 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.45999440 |
| 112 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.45709626 |
| 113 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.45362715 |
| 114 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.44723292 |
| 115 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.44391822 |
| 116 | Platelet activation_Homo sapiens_hsa04611 | 0.44350287 |
| 117 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.43689308 |
| 118 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.42555904 |
| 119 | Tight junction_Homo sapiens_hsa04530 | 0.42185886 |
| 120 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38963756 |
| 121 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.38868293 |
| 122 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38577199 |
| 123 | Circadian rhythm_Homo sapiens_hsa04710 | 0.38497436 |
| 124 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.38157590 |
| 125 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36793723 |
| 126 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.36668648 |
| 127 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.36426688 |
| 128 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.35952086 |
| 129 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.35708655 |
| 130 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.35636240 |
| 131 | Purine metabolism_Homo sapiens_hsa00230 | 0.35522457 |
| 132 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.34761188 |
| 133 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.32859621 |
| 134 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.32253449 |
| 135 | Amoebiasis_Homo sapiens_hsa05146 | 0.31649670 |
| 136 | Carbon metabolism_Homo sapiens_hsa01200 | 0.28283906 |

